Skip to content

This report is written by MaltSci based on the latest literature and research findings


What is the role of telomeres in cellular aging?

Abstract

Telomeres, the protective caps at the ends of linear chromosomes, are crucial for maintaining genomic stability and regulating cellular aging. As cells divide, telomeres shorten due to the end-replication problem, leading to cellular senescence when they become critically short. This review examines the multifaceted role of telomeres in cellular aging, focusing on their structure, function, and the mechanisms underlying telomere shortening. We discuss how telomere attrition contributes to cellular senescence and its implications for age-related diseases such as cancer and cardiovascular disorders. Additionally, we explore the impact of lifestyle factors, including diet and physical activity, on telomere length, highlighting the potential for lifestyle modifications to promote healthy aging. Emerging therapeutic strategies aimed at preserving telomere length and enhancing telomerase activity are also considered, with an emphasis on their promise for extending healthspan and mitigating the effects of aging. Overall, this review underscores the critical importance of telomeres in aging biology and the need for ongoing research to unlock their therapeutic potential.

Outline

This report will discuss the following questions.

  • 1 Introduction
  • 2 The Structure and Function of Telomeres
    • 2.1 Composition and Organization of Telomeres
    • 2.2 Telomerase and Its Role in Telomere Maintenance
  • 3 Telomere Shortening and Cellular Aging
    • 3.1 Mechanisms of Telomere Shortening
    • 3.2 Cellular Senescence and the Role of Telomeres
  • 4 Telomeres in Age-Related Diseases
    • 4.1 Telomere Length and Cancer
    • 4.2 Telomeres in Cardiovascular and Metabolic Diseases
  • 5 Lifestyle Factors Affecting Telomere Length
    • 5.1 Impact of Diet and Nutrition
    • 5.2 Role of Physical Activity and Stress Management
  • 6 Therapeutic Approaches Targeting Telomeres
    • 6.1 Telomerase Activation Strategies
    • 6.2 Potential Pharmacological Interventions
  • 7 Conclusion

1 Introduction

Telomeres, the protective caps at the ends of linear chromosomes, play a critical role in maintaining genomic stability and regulating cellular aging. These repetitive nucleotide sequences serve to prevent chromosome degradation and fusion, which can lead to genomic instability and cellular senescence. As cells divide, telomeres shorten due to the end-replication problem inherent in DNA replication. This progressive telomere shortening has been closely associated with cellular aging, as critically short telomeres can activate DNA damage responses that halt cell division and trigger senescence [1][2]. The understanding of telomere biology has evolved significantly over the past few decades, highlighting its relevance not only in the aging process but also in various age-related diseases, including cancer, cardiovascular diseases, and metabolic disorders [3][4].

The significance of telomeres in aging extends beyond mere cellular replication limits; they are implicated in the broader biological mechanisms that underlie aging and age-related pathologies. Telomere shortening is recognized as a hallmark of aging, influencing various cellular processes such as proliferation, apoptosis, and stress responses [5][6]. The accumulation of senescent cells, which are characterized by short telomeres, contributes to tissue dysfunction and the overall decline in physiological capabilities associated with aging [7][8]. Moreover, recent research has uncovered the role of telomere-associated transcripts and their involvement in age-related signaling pathways, suggesting that telomeres may act as sensors for cellular stress and environmental factors [3][9].

Current research trends have begun to explore the intricate relationships between lifestyle factors, telomere dynamics, and health outcomes. Factors such as diet, physical activity, and stress management have been shown to influence telomere length and integrity [10][11]. For instance, specific dietary components, such as antioxidants, may protect telomeres from oxidative stress, thereby modulating the aging process [11]. Understanding these connections not only sheds light on the biological mechanisms of aging but also offers potential therapeutic avenues for promoting healthy aging through lifestyle modifications and pharmacological interventions aimed at preserving telomere length [12][13].

In this review, we will delve into the multifaceted role of telomeres in cellular aging, organized into several key sections. We will begin by examining the structure and function of telomeres, including their composition and the role of telomerase in telomere maintenance. Following this, we will discuss the mechanisms underlying telomere shortening and its implications for cellular senescence. The review will also explore the relationship between telomeres and age-related diseases, highlighting their roles in cancer and cardiovascular conditions. We will further investigate lifestyle factors that impact telomere length, followed by an overview of emerging therapeutic strategies targeting telomeres. Finally, we will conclude by summarizing the current state of research and its implications for understanding aging and age-related diseases.

Through this comprehensive examination, we aim to elucidate the critical role of telomeres in cellular aging and emphasize the importance of ongoing research in this area, which holds promise for developing interventions to enhance healthspan and mitigate the effects of aging on human health.

2 The Structure and Function of Telomeres

2.1 Composition and Organization of Telomeres

Telomeres are specialized structures located at the ends of linear eukaryotic chromosomes, consisting of repetitive DNA sequences that serve several critical functions in cellular aging. Their primary role is to protect chromosome ends from degradation and illegitimate recombination, thus maintaining genomic stability. As cells divide, telomeres progressively shorten due to the 'end-replication problem,' which occurs because DNA polymerases cannot fully replicate the ends of linear DNA molecules. This shortening is a significant contributor to cellular senescence, a state of permanent cell cycle arrest, which is a hallmark of aging.

The structure of telomeres is composed of tandem repeats of the sequence TTAGGG in vertebrates, along with associated proteins that form a protective cap. This cap is crucial for preventing the activation of DNA damage response pathways that would otherwise be triggered by the exposure of chromosome ends. When telomeres become critically short or dysfunctional, they can no longer adequately protect chromosome ends, leading to cellular senescence or apoptosis. This process is particularly relevant in somatic cells, where telomerase activity is typically low or absent, limiting the capacity for telomere maintenance. In contrast, germline cells express high levels of telomerase, allowing them to maintain telomere length throughout the organism's life.

The relationship between telomeres and aging is underscored by the observation that telomere length declines with age, contributing to the loss of proliferative capacity in stem and somatic cells. For instance, in individuals with mutations affecting telomerase activity, such as those with dyskeratosis congenita, telomere shortening is linked to various age-related diseases, including pulmonary fibrosis and cancer. These patients exhibit symptoms of premature aging, highlighting the essential role of telomeres in regulating cellular lifespan and health.

Recent studies have also explored the transcriptional activity of telomeres, revealing that certain long non-coding RNAs, such as TElomeric Repeat-containing RNA (TERRA), play a role in telomere protection and maintenance. These transcripts are involved in regulating telomere length and signaling pathways related to DNA damage, further emphasizing the complexity of telomere biology in aging processes.

In summary, telomeres function as protective caps that prevent genomic instability, and their progressive shortening is a fundamental mechanism underlying cellular aging. The intricate relationship between telomere length, telomerase activity, and cellular senescence highlights the importance of telomeres in the aging process and their potential as targets for therapeutic interventions aimed at extending healthy lifespan and mitigating age-related diseases[1][2][3].

2.2 Telomerase and Its Role in Telomere Maintenance

Telomeres are repetitive DNA sequences located at the ends of eukaryotic chromosomes, and they play a crucial role in maintaining chromosomal stability and regulating cellular aging. Each time a cell divides, telomeres shorten due to the end-replication problem, leading to a limit on the number of times a cell can divide, known as the Hayflick limit. This process is fundamental to cellular aging, as progressive telomere shortening is associated with cellular senescence, a state of permanent growth arrest that occurs when telomeres become critically short or dysfunctional [1][14].

The maintenance of telomere length is primarily facilitated by the enzyme telomerase, which is a reverse transcriptase that adds telomeric DNA repeats to the ends of chromosomes. In most somatic cells, telomerase activity is low or absent, leading to gradual telomere shortening over time. This decline in telomere length poses a barrier to tumor growth but also contributes to the loss of functional cells with age [1][2]. The average telomere length is maintained in germline cells, which typically express high levels of telomerase, thereby allowing these cells to retain their replicative capacity [14].

In addition to their role in cellular aging, telomeres and telomerase have been implicated in various age-related diseases. For instance, patients with mutations in telomerase genes often exhibit significantly shortened telomeres and are predisposed to disorders such as dyskeratosis congenita, aplastic anemia, pulmonary fibrosis, and certain cancers [1]. The relationship between telomere length and aging-related diseases underscores the importance of telomere maintenance in cellular health and longevity.

Recent studies have also highlighted that telomerase may have functions beyond mere telomere maintenance. It is involved in various cellular processes, including apoptosis, DNA repair, and gene expression regulation, which may contribute to cellular longevity and resilience against age-related damage [14]. Thus, while telomeres serve as protective caps that prevent chromosomal degradation, the regulation of telomerase activity is critical for both maintaining telomere length and modulating the aging process.

Overall, the dynamics of telomere shortening and telomerase activity represent a complex interplay that is central to understanding cellular aging, organismal longevity, and the development of age-associated diseases. The ongoing research in this field continues to uncover the intricate mechanisms by which telomeres and telomerase influence healthspan and lifespan, offering potential therapeutic targets for age-related conditions [15][16].

3 Telomere Shortening and Cellular Aging

3.1 Mechanisms of Telomere Shortening

Telomeres, the protective structures at the ends of linear chromosomes, play a crucial role in cellular aging by maintaining genome stability and regulating cellular lifespan. They consist of repetitive DNA sequences that protect chromosome ends from degradation and prevent inappropriate recombination. As cells undergo division, telomeres shorten due to the limitations of DNA replication, which is a key feature of aging. This progressive shortening leads to cellular senescence, a state of permanent growth arrest, and contributes to various age-related pathologies.

The mechanisms underlying telomere shortening are multifaceted. Firstly, during each cell division, a portion of the telomere is lost because DNA polymerases cannot fully replicate the ends of linear chromosomes, a phenomenon known as the "end replication problem" (Aubert & Lansdorp, 2008; Victorelli & Passos, 2017). Additionally, telomeres are susceptible to oxidative stress, which can exacerbate their shortening by damaging the DNA within these regions (Zhang et al., 2016; Assalve et al., 2025). Chronic inflammation and oxidative imbalance are further contributors to telomere attrition, leading to a vicious cycle that promotes aging and age-associated diseases (Rakoczy et al., 2025).

The relationship between telomere shortening and cellular senescence is well established. Senescent cells accumulate in tissues with age and are associated with the loss of tissue function and the onset of age-related diseases (Wright & Shay, 2001; Aubert & Lansdorp, 2008). Shortened telomeres activate DNA damage response pathways, leading to the expression of cell cycle inhibitors such as p53, which enforces senescence (Shawi & Autexier, 2008). This senescent state not only halts cell proliferation but also alters the tissue microenvironment, contributing to inflammation and tissue degeneration (Zhang et al., 2016; Assalve et al., 2025).

Furthermore, telomere shortening has implications for stem cell function. As stem cells replicate, their telomeres shorten, which can limit their regenerative capacity and contribute to the decline of tissue homeostasis with age (Song et al., 2009). In this context, telomeres act as biological clocks, determining the replicative potential of stem cells and influencing their ability to respond to injury or stress (Ullah & Sun, 2019).

In summary, telomeres are integral to cellular aging through their role in maintaining genome integrity and regulating cell proliferation. The progressive shortening of telomeres leads to cellular senescence, which is associated with the decline in tissue function and the development of age-related diseases. Understanding the mechanisms of telomere shortening and their impact on cellular aging is essential for developing potential therapeutic strategies aimed at mitigating the effects of aging and enhancing healthspan.

3.2 Cellular Senescence and the Role of Telomeres

Telomeres, the repetitive DNA sequences located at the ends of eukaryotic chromosomes, play a crucial role in cellular aging and the processes associated with it, such as cellular senescence. Their primary function is to protect chromosome ends from degradation and prevent the activation of DNA damage responses. Each time a cell divides, telomeres shorten due to the end-replication problem, which leads to a progressive decline in their length. This shortening ultimately triggers cellular senescence, a state of irreversible growth arrest characterized by various phenotypic changes associated with aging [17].

As telomeres become critically short, they can no longer effectively cap chromosome ends, leading to the activation of DNA damage response pathways. This results in a series of cellular responses including apoptosis or senescence when too many uncapped telomeres accumulate [1]. In somatic cells, where telomerase activity is typically low, the average telomere length declines with age, which not only serves as a barrier to tumor growth but also contributes to the loss of functional cells over time [2].

Cellular senescence is increasingly recognized as a significant contributor to the aging process and age-related diseases. The accumulation of senescent cells in tissues leads to a decline in tissue function and contributes to the pathophysiology of various age-associated disorders [7]. Telomeres are implicated in this process as they act as sensors of both intrinsic and extrinsic stress, signaling the cell to enter a state of senescence in response to accumulated DNA damage [18].

Moreover, recent studies have highlighted the role of telomere transcription in aging. Telomeric transcripts, such as TElomeric Repeat-containing RNA (TERRA), are involved in chromosome end protection and the maintenance of genome stability. Dysfunctional telomeres can lead to replicative senescence and chromosomal instability, which are hallmarks of aging [3].

In summary, telomeres play a central role in regulating cellular aging through their influence on cellular senescence. The progressive shortening of telomeres with each cell division leads to a state of growth arrest, contributing to the functional decline observed in aging tissues and the development of age-related diseases. Understanding the mechanisms by which telomeres influence aging may provide insights into potential therapeutic strategies aimed at mitigating the effects of aging and promoting healthspan.

4.1 Telomere Length and Cancer

Telomeres, the protective caps located at the ends of eukaryotic chromosomes, play a critical role in cellular aging, age-related diseases, and cancer. They are composed of repetitive DNA sequences that safeguard the integrity and stability of chromosomes during cell division. As cells divide, telomeres gradually shorten, a process that is linked to the aging of the cell. When telomeres become critically short, they trigger cellular senescence or apoptosis, effectively limiting the number of times a cell can divide. This phenomenon has been well-documented, indicating that telomere attrition is a fundamental aspect of the aging process [19].

In terms of age-related diseases, the shortening of telomeres is closely associated with various conditions, including cancer. Research has shown that genetic diseases resulting in telomerase deficiency are linked to premature aging and an increased risk of cancer [20]. Short telomeres have been identified as significant contributors to the pathogenesis of age-related disorders, as they lead to genomic instability and may facilitate the emergence of malignant cells [1].

Conversely, long telomeres have also been implicated in cancer development. While they are generally associated with extended cellular lifespan in vitro, they have been identified as a common germline risk factor for cancer in population studies [13]. This duality suggests that both short and long telomeres can influence cancer evolution, albeit through distinct mechanisms [13].

Furthermore, telomeres interact with various molecular pathways that are crucial for cellular response to stress and growth stimulation. The average telomere length is maintained in germline cells, which express high levels of telomerase, an enzyme that adds nucleotide sequences to telomeres, counteracting their shortening [1]. In somatic cells, however, telomerase activity is limited, leading to a progressive decline in telomere length with age [21]. This loss of telomere length serves as a barrier to tumor growth but simultaneously contributes to the loss of normal cells, thereby creating a selection pressure for abnormal or malignant cells [1].

Recent studies emphasize the importance of understanding the dynamic nature of telomeres in the context of aging and cancer. For instance, fragile telomeres characterized by replication stress may provide insights into the aging-cancer connection [22]. The interdependence of telomere biology and inflammatory processes further complicates the relationship, as inflammation is known to accelerate telomere shortening and is implicated in chronic age-related diseases [23].

In summary, telomeres play a pivotal role in cellular aging by regulating cell division and genomic stability. Their length is a crucial determinant of susceptibility to age-related diseases, including cancer, with both short and long telomeres contributing to disease processes through different mechanisms. Understanding these dynamics is essential for developing therapeutic strategies aimed at promoting healthy aging and mitigating cancer risk [24].

4.2 Telomeres in Cardiovascular and Metabolic Diseases

Telomeres are specialized structures located at the ends of eukaryotic chromosomes, composed of repetitive nucleotide sequences that serve crucial functions in maintaining genomic stability and integrity. Their role in cellular aging is particularly significant, as they undergo progressive shortening with each cell division, a process that has profound implications for cellular senescence and organismal aging.

In the context of cellular aging, telomeres play a central role by adjusting the cellular response to stress and growth stimulation based on prior cell divisions and DNA damage. The protective function of telomeres is essential; each chromosome end must be capped with a few hundred nucleotides of telomere repeats to prevent the activation of DNA repair pathways that could lead to genomic instability. When telomeres become critically short or "uncapped," most somatic cells experience apoptosis or senescence, a process that is exacerbated as average telomere length decreases with age (Aubert and Lansdorp, 2008) [1].

Telomere shortening is closely linked to various age-related diseases, including cardiovascular disease (CVD), malignancies, and neurodegenerative disorders. Aging is characterized by not only the progressive shortening of telomeres but also by a compromised telomere structure and function, which contributes to the pathogenesis of these diseases. For instance, in cardiovascular diseases, telomere attrition is believed to induce genomic instability, replicative senescence, and apoptosis, all of which contribute to the aging process and increase the risk of CVD (Fuster and Andrés, 2006) [25]. The relationship between telomere length and cardiovascular risk factors such as oxidative stress, hypertension, and diabetes has been established, suggesting that telomere shortening could be both a cause and a consequence of cardiovascular pathology (Edo and Andrés, 2005) [26].

Moreover, telomeres have been implicated in the regulation of inflammation, which is another critical factor in aging and age-related diseases. Critically short telomeres can trigger cellular senescence, leading to increased inflammatory cytokine production, which may further exacerbate age-related chronic conditions (Zhang et al., 2016) [23]. This interconnectedness suggests that telomere biology could be a vital area of focus for understanding the mechanisms underlying age-related diseases and for developing potential therapeutic interventions.

In summary, telomeres are integral to the aging process and the development of age-related diseases. Their shortening is a hallmark of cellular aging, influencing not only the longevity of cells but also their functional capacity, thereby playing a pivotal role in the onset and progression of various diseases, particularly cardiovascular and metabolic disorders. The understanding of telomere biology continues to evolve, highlighting the need for further research to explore the therapeutic potential of targeting telomere maintenance mechanisms in age-related diseases.

5 Lifestyle Factors Affecting Telomere Length

5.1 Impact of Diet and Nutrition

Telomeres, the protective structures at the ends of linear chromosomes, play a critical role in cellular aging by regulating cell fate and the response to stress. As cells divide, telomeres gradually shorten due to the "end-replication problem," which limits the replicative potential of somatic cells. When telomeres become critically short or "uncapped," they trigger cellular senescence or apoptosis, contributing to aging and age-associated diseases [1].

Recent findings indicate that various lifestyle factors, particularly diet and nutrition, significantly influence telomere length (TL) and, consequently, the aging process. Studies have shown that shorter telomeres are associated with increased incidence of diseases and poorer survival outcomes [27]. Conversely, specific lifestyle modifications can slow down the rate of telomere shortening, thereby potentially extending healthspan and lifespan [28].

Diet plays a pivotal role in telomere maintenance. A diet rich in antioxidants, vitamins, and healthy fats has been correlated with longer telomeres. For instance, diets high in fruits, vegetables, and whole grains provide essential nutrients that combat oxidative stress, which is known to accelerate telomere attrition [29]. Moreover, adequate intake of omega-3 fatty acids and other anti-inflammatory nutrients may help preserve telomere length by mitigating the inflammatory processes that contribute to cellular aging [30].

Physical activity is another lifestyle factor that has a positive association with telomere length. Regular physical activity is believed to reduce oxidative stress and inflammation, which are detrimental to telomere integrity. Research suggests that individuals who engage in consistent physical activity tend to have longer telomeres compared to sedentary individuals [28].

In summary, telomeres serve as critical markers of cellular aging, and their length is influenced by lifestyle factors such as diet and physical activity. Adopting a healthy lifestyle that includes a balanced diet rich in antioxidants and regular physical exercise may reduce the rate of telomere shortening, thus delaying the onset of age-associated diseases and potentially extending lifespan [27][28][29].

5.2 Role of Physical Activity and Stress Management

Telomeres, which are repetitive nucleotide sequences located at the ends of chromosomes, play a critical role in cellular aging by serving as protective caps that prevent genomic instability. As cells divide, telomeres gradually shorten due to the end-replication problem, leading to a point where they can no longer effectively protect the chromosome ends. This shortening is associated with cellular senescence, apoptosis, and oncogenic transformation, thereby influencing the aging process and the onset of age-related diseases[1].

Recent studies have demonstrated that various lifestyle factors can significantly affect telomere length, thereby modulating the rate of cellular aging. Specifically, physical activity and stress management have emerged as key factors in influencing telomere dynamics. Regular physical activity has been shown to have a protective effect on telomeres. For instance, a study involving a large cohort of adults indicated that participation in strength training is associated with longer telomeres and a reduction in biological aging. Specifically, engaging in 90 minutes of strength training per week was linked to an average of 3.9 years less biological aging[31]. This relationship suggests that physical activity may help preserve telomere length by activating telomerase, the enzyme responsible for adding nucleotides to telomeres, thus counteracting the effects of telomere shortening[32].

In addition to physical activity, stress management also plays a significant role in telomere maintenance. Chronic psychological stress has been implicated in telomere shortening, as stress-induced mechanisms can lead to DNA damage and cellular senescence[33]. Stress affects telomere biology through various pathways, including the action of glucocorticoids and the production of reactive oxygen species (ROS), both of which can exacerbate telomere attrition[33]. Conversely, practices such as mindfulness meditation may mitigate the negative effects of stress on telomeres by reducing stress arousal and enhancing positive psychological states[34].

Moreover, the relationship between lifestyle factors and telomere length is complex and multifaceted. It is influenced not only by physical activity and stress management but also by dietary choices and other modifiable variables[27]. Studies have indicated that healthier lifestyles, characterized by better nutrition and regular exercise, can slow down the rate of telomere shortening, thereby promoting longevity and reducing the incidence of age-associated diseases[29].

In summary, telomeres are crucial in cellular aging, acting as protective caps that, when shortened, lead to cellular senescence and increased disease risk. Lifestyle factors such as physical activity and stress management are instrumental in maintaining telomere length, thus potentially delaying the aging process and improving overall health outcomes. The integration of regular exercise and effective stress management strategies can serve as vital components in the modulation of telomere dynamics and the promotion of longevity.

6 Therapeutic Approaches Targeting Telomeres

6.1 Telomerase Activation Strategies

Telomeres, the protective structures at the ends of chromosomes, play a crucial role in cellular aging and the maintenance of genomic stability. Each time a cell divides, telomeres shorten due to the "end-replication problem," which limits the number of times a cell can replicate. This progressive shortening eventually leads to cellular senescence, a state of irreversible growth arrest that is a hallmark of aging. Dysfunctional telomeres can activate DNA damage response pathways, contributing to chromosome instability and the development of age-related diseases [1][2][35].

The relationship between telomeres and aging has prompted significant interest in therapeutic strategies aimed at preserving telomere length or enhancing telomerase activity. Telomerase, an enzyme that elongates telomeres, is typically inactive in most somatic cells but is expressed in germ cells, stem cells, and many cancer cells. By reactivating telomerase, it is possible to extend the replicative lifespan of cells, potentially delaying the onset of age-related pathologies [15][36].

Recent advancements in telomerase activation strategies have explored various approaches, including gene therapy to introduce telomerase components into somatic cells, small molecules that enhance telomerase activity, and the use of oncolytic viruses that are driven by telomerase promoters [35][37]. Additionally, compounds such as ginsenoside F1 have shown promise in preserving telomere integrity by restoring telomeric protein levels, which in turn may delay cellular senescence [38].

However, the therapeutic use of telomerase activation presents challenges, particularly regarding the potential for increased cancer risk due to the reintroduction of cellular immortality. Therefore, careful consideration of the balance between the benefits of telomerase activation for healthy aging and the risks associated with tumorigenesis is essential [39][40]. The ongoing research aims to elucidate the mechanisms by which telomerase can be safely and effectively targeted to enhance healthspan and longevity while mitigating associated risks [41][42].

In summary, telomeres are integral to the aging process, and therapeutic approaches targeting telomerase activation hold potential for extending cellular lifespan and combating age-related diseases. Continued exploration of these strategies will be crucial in advancing our understanding of aging and developing effective interventions.

6.2 Potential Pharmacological Interventions

Telomeres, the protective caps at the ends of eukaryotic chromosomes, play a pivotal role in cellular aging by maintaining genomic stability and regulating cellular lifespan. As cells undergo division, telomeres progressively shorten due to the "end-replication problem," which limits the number of times a cell can divide before it enters a state of replicative senescence or apoptosis. This shortening is a key factor in the aging process, as critically short telomeres can trigger DNA damage responses, leading to cellular dysfunction and contributing to age-related pathologies [1][3].

Recent studies have elucidated the mechanisms by which telomeres influence cellular aging. For instance, telomeres serve to cap chromosome ends and prevent them from being recognized as damaged DNA, thus avoiding activation of DNA repair pathways that can lead to genomic instability [3]. When telomeres become dysfunctional, they can result in replicative senescence, which is associated with a variety of age-related diseases [35]. Furthermore, telomere attrition is linked to a spectrum of degenerative conditions, including cardiovascular diseases, neurodegenerative disorders, and certain cancers [42].

Therapeutic approaches targeting telomeres have gained attention as potential interventions to combat aging and its associated diseases. One promising strategy involves telomerase modulation, which aims to restore telomere length and function. Telomerase is an enzyme that can extend telomeres, thereby delaying cellular senescence and promoting cell proliferation. However, while telomerase activation may provide benefits in terms of extending lifespan and improving tissue regeneration, it also poses risks, such as the potential for oncogenesis [15][43].

In addition to telomerase activation, other pharmacological interventions are being explored. These include the use of natural compounds, such as ginsenoside F1, which has been shown to preserve telomere integrity and delay cellular senescence by restoring telomere-binding proteins like TRF2 [38]. Furthermore, antisense oligonucleotides targeting telomeric non-coding RNAs, such as TERRA, have emerged as potential therapeutic strategies to enhance telomere protection and stability [3].

The convergence of mechanistic understanding of telomere biology with innovative therapeutic strategies positions telomere-targeted medicine as a promising frontier in addressing age-related conditions. This approach not only aims to mitigate the effects of aging but also seeks to shift the focus of medicine from reactive disease treatment to proactive aging-focused prevention [42].

In summary, telomeres are central to cellular aging, and therapeutic strategies targeting telomere biology, including telomerase modulation and novel pharmacological interventions, hold potential for extending healthspan and addressing age-related diseases. However, further research is needed to navigate the complexities and challenges associated with these interventions to ensure their safety and efficacy [37][44].

7 Conclusion

The exploration of telomeres and their role in cellular aging has unveiled critical insights into the mechanisms that govern cellular lifespan and the onset of age-related diseases. Key findings highlight that telomeres, through their progressive shortening during cell division, are integral to cellular senescence and the maintenance of genomic stability. This understanding has led to a deeper appreciation of how telomere dynamics influence various age-related pathologies, including cancer and cardiovascular diseases. Current research emphasizes the importance of lifestyle factors, such as diet and physical activity, in modulating telomere length and thereby impacting healthspan. Looking forward, the potential for therapeutic interventions targeting telomeres, including telomerase activation and pharmacological strategies, presents exciting avenues for enhancing longevity and mitigating age-associated diseases. However, careful consideration of the risks, particularly regarding oncogenesis, is essential as we navigate the complexities of telomere biology in the quest for effective aging interventions.

References

  • [1] Geraldine Aubert;Peter M Lansdorp. Telomeres and aging.. Physiological reviews(IF=28.7). 2008. PMID:18391173. DOI: 10.1152/physrev.00026.2007.
  • [2] Peter M Lansdorp. Telomeres, stem cells, and hematology.. Blood(IF=23.1). 2008. PMID:18263784. DOI: 10.1182/blood-2007-09-084913.
  • [3] Julio Aguado;Fabrizio d'Adda di Fagagna;Ernst Wolvetang. Telomere transcription in ageing.. Ageing research reviews(IF=12.4). 2020. PMID:32565330. DOI: 10.1016/j.arr.2020.101115.
  • [4] Yukun Zhu;Xuewen Liu;Xuelu Ding;Fei Wang;Xin Geng. Telomere and its role in the aging pathways: telomere shortening, cell senescence and mitochondria dysfunction.. Biogerontology(IF=4.1). 2019. PMID:30229407. DOI: 10.1007/s10522-018-9769-1.
  • [5] W E Wright;J W Shay. Cellular senescence as a tumor-protection mechanism: the essential role of counting.. Current opinion in genetics & development(IF=3.6). 2001. PMID:11163158. DOI: 10.1016/s0959-437x(00)00163-5.
  • [6] Dora Melicher;Edit I Buzas;Andras Falus. Genetic and epigenetic trends in telomere research: a novel way in immunoepigenetics.. Cellular and molecular life sciences : CMLS(IF=6.2). 2015. PMID:26190020. DOI: 10.1007/s00018-015-1991-2.
  • [7] Stella Victorelli;João F Passos. Telomeres and Cell Senescence - Size Matters Not.. EBioMedicine(IF=10.8). 2017. PMID:28347656. DOI: 10.1016/j.ebiom.2017.03.027.
  • [8] Alain Chebly;Charbel Khalil;Alexandra Kuzyk;Marie Beylot-Barry;Edith Chevret. T-cell lymphocytes' aging clock: telomeres, telomerase and aging.. Biogerontology(IF=4.1). 2024. PMID:37917220. DOI: 10.1007/s10522-023-10075-6.
  • [9] Deepavali Chakravarti;Kyle A LaBella;Ronald A DePinho. Telomeres: history, health, and hallmarks of aging.. Cell(IF=42.5). 2021. PMID:33450206. DOI: 10.1016/j.cell.2020.12.028.
  • [10] Katarzyna Rakoczy;Laura Wojdyło;Sara Suwała;Karolina Klasen;Jacek Kuźnicki;Marek Ziętek;Julita Kulbacka. Correlations between Aging, Telomeres, and Natural Compounds.. Aging and disease(IF=6.9). 2025. PMID:41135091. DOI: 10.14336/AD.2025.0853.
  • [11] Virginia Boccardi;Beatrice Arosio;Luigi Cari;Patrizia Bastiani;Michela Scamosci;Martina Casati;Evelyn Ferri;Laura Bertagnoli;Simona Ciccone;Paolo Dionigi Rossi;Giuseppe Nocentini;Patrizia Mecocci. Beta-carotene, telomerase activity and Alzheimer's disease in old age subjects.. European journal of nutrition(IF=4.3). 2020. PMID:30649596. DOI: 10.1007/s00394-019-01892-y.
  • [12] He Li;Jun-Ping Liu. Signaling on telomerase: a master switch in cell aging and immortalization.. Biogerontology(IF=4.1). 2002. PMID:12014828. DOI: 10.1023/a:1015232102470.
  • [13] Mary Armanios. The Role of Telomeres in Human Disease.. Annual review of genomics and human genetics(IF=7.9). 2022. PMID:35609925. DOI: 10.1146/annurev-genom-010422-091101.
  • [14] Yusheng Cong;Jerry W Shay. Actions of human telomerase beyond telomeres.. Cell research(IF=25.9). 2008. PMID:18574498. DOI: 10.1038/cr.2008.74.
  • [15] Virginia Boccardi;Giuseppe Paolisso. Telomerase activation: a potential key modulator for human healthspan and longevity.. Ageing research reviews(IF=12.4). 2014. PMID:24561251. DOI: .
  • [16] Mayya P Razgonova;Alexander M Zakharenko;Kirill S Golokhvast;Maria Thanasoula;Evangelia Sarandi;Konstantinos Nikolouzakis;Persefoni Fragkiadaki;Dimitris Tsoukalas;Demetrios A Spandidos;Aristidis Tsatsakis. Telomerase and telomeres in aging theory and chronographic aging theory (Review).. Molecular medicine reports(IF=3.5). 2020. PMID:32705188. DOI: 10.3892/mmr.2020.11274.
  • [17] Tohru Minamino;Issei Komuro. Role of telomere in endothelial dysfunction in atherosclerosis.. Current opinion in lipidology(IF=4.6). 2002. PMID:12352018. DOI: 10.1097/00041433-200210000-00010.
  • [18] João Pedro de Magalhães;João F Passos. Stress, cell senescence and organismal ageing.. Mechanisms of ageing and development(IF=5.1). 2018. PMID:28688962. DOI: 10.1016/j.mad.2017.07.001.
  • [19] Huanjiu Xi;Changyong Li;Fu Ren;Hailong Zhang;Luping Zhang. Telomere, aging and age-related diseases.. Aging clinical and experimental research(IF=3.4). 2013. PMID:23739898. DOI: 10.1007/s40520-013-0021-1.
  • [20] Madalena C Carneiro;Inês Pimenta de Castro;Miguel Godinho Ferreira. Telomeres in aging and disease: lessons from zebrafish.. Disease models & mechanisms(IF=3.3). 2016. PMID:27482813. DOI: 10.1242/dmm.025130.
  • [21] Ali Ahmed;Trygve Tollefsbol. Telomeres, telomerase, and telomerase inhibition: clinical implications for cancer.. Journal of the American Geriatrics Society(IF=4.5). 2003. PMID:12534855. DOI: 10.1034/j.1601-5215.2002.51019.x.
  • [22] Virginia Boccardi;Luigi Marano. The telomere connection between aging and cancer: The burden of replication stress and dysfunction.. Mechanisms of ageing and development(IF=5.1). 2025. PMID:39805504. DOI: 10.1016/j.mad.2025.112026.
  • [23] Jingwen Zhang;Grishma Rane;Xiaoyun Dai;Muthu K Shanmugam;Frank Arfuso;Ramar Perumal Samy;Mitchell Kim Peng Lai;Dennis Kappei;Alan Prem Kumar;Gautam Sethi. Ageing and the telomere connection: An intimate relationship with inflammation.. Ageing research reviews(IF=12.4). 2016. PMID:26616852. DOI: .
  • [24] Pan Liao;Bo Yan;Conglin Wang;Ping Lei. Telomeres: Dysfunction, Maintenance, Aging and Cancer.. Aging and disease(IF=6.9). 2023. PMID:38270117. DOI: 10.14336/AD.2023.1128.
  • [25] José J Fuster;Vicente Andrés. Telomere biology and cardiovascular disease.. Circulation research(IF=16.2). 2006. PMID:17122447. DOI: 10.1161/01.RES.0000251281.00845.18.
  • [26] María Dolores Edo;Vicente Andrés. Aging, telomeres, and atherosclerosis.. Cardiovascular research(IF=13.3). 2005. PMID:15820190. DOI: 10.1016/j.cardiores.2004.09.007.
  • [27] Masood A Shammas. Telomeres, lifestyle, cancer, and aging.. Current opinion in clinical nutrition and metabolic care(IF=3.5). 2011. PMID:21102320. DOI: 10.1097/MCO.0b013e32834121b1.
  • [28] Bartu Eren Güneşliol;Esen Karaca;Duygu Ağagündüz;Zeynep Alanur Acar. Association of physical activity and nutrition with telomere length, a marker of cellular aging: A comprehensive review.. Critical reviews in food science and nutrition(IF=8.8). 2023. PMID:34553645. DOI: 10.1080/10408398.2021.1952402.
  • [29] Nikolina Škrobot Vidacek;Lucia Nanic;Sanda Ravlic;Mary Sopta;Marko Geric;Goran Gajski;Vera Garaj-Vrhovac;Ivica Rubelj. Telomeres, Nutrition, and Longevity: Can We Really Navigate Our Aging?. The journals of gerontology. Series A, Biological sciences and medical sciences(IF=3.8). 2017. PMID:28510637. DOI: 10.1093/gerona/glx082.
  • [30] Estelle Balan;Anabelle Decottignies;Louise Deldicque. Physical Activity and Nutrition: Two Promising Strategies for Telomere Maintenance?. Nutrients(IF=5.0). 2018. PMID:30544511. DOI: 10.3390/nu10121942.
  • [31] Larry A Tucker;Carson J Bates. Telomere Length and Biological Aging: The Role of Strength Training in 4814 US Men and Women.. Biology(IF=3.5). 2024. PMID:39596838. DOI: 10.3390/biology13110883.
  • [32] Maria Donatella Semeraro;Cassandra Smith;Melanie Kaiser;Itamar Levinger;Gustavo Duque;Hans-Juergen Gruber;Markus Herrmann. Physical activity, a modulator of aging through effects on telomere biology.. Aging(IF=3.9). 2020. PMID:32575077. DOI: 10.18632/aging.103504.
  • [33] Jue Lin;Elissa Epel. Stress and telomere shortening: Insights from cellular mechanisms.. Ageing research reviews(IF=12.4). 2022. PMID:34736994. DOI: 10.1016/j.arr.2021.101507.
  • [34] Elissa Epel;Jennifer Daubenmier;Judith Tedlie Moskowitz;Susan Folkman;Elizabeth Blackburn. Can meditation slow rate of cellular aging? Cognitive stress, mindfulness, and telomeres.. Annals of the New York Academy of Sciences(IF=4.8). 2009. PMID:19735238. DOI: 10.1111/j.1749-6632.2009.04414.x.
  • [35] Michel M Ouellette;Woodring E Wright;Jerry W Shay. Targeting telomerase-expressing cancer cells.. Journal of cellular and molecular medicine(IF=4.2). 2011. PMID:21332640. DOI: 10.1111/j.1582-4934.2011.01279.x.
  • [36] M Fossel. Telomerase and the aging cell: implications for human health.. JAMA(IF=55.0). 1998. PMID:9624027. DOI: 10.1001/jama.279.21.1732.
  • [37] Carlota Tavares-Marcos;Magda Correia;Bruno Bernardes de Jesus. Telomeres as hallmarks of iPSC aging: A review on telomere dynamics during stemness and cellular reprogramming.. Ageing research reviews(IF=12.4). 2025. PMID:40414363. DOI: 10.1016/j.arr.2025.102773.
  • [38] Jingang Hou;Yeejin Yun;Byeongmin Jeon;Jongin Baek;Sunchang Kim. Ginsenoside F1-Mediated Telomere Preservation Delays Cellular Senescence.. International journal of molecular sciences(IF=4.9). 2023. PMID:37762556. DOI: 10.3390/ijms241814241.
  • [39] Christoph Geserick;Maria A Blasco. Novel roles for telomerase in aging.. Mechanisms of ageing and development(IF=5.1). 2006. PMID:16516269. DOI: 10.1016/j.mad.2006.01.017.
  • [40] Karima Ait-Aissa;Johnathan D Ebben;Andrew O Kadlec;Andreas M Beyer. Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease.. Pharmacological research(IF=10.5). 2016. PMID:27394166. DOI: 10.1016/j.phrs.2016.07.003.
  • [41] Xuanqi Huang;Leyi Huang;Jiaweng Lu;Lijuan Cheng;Du Wu;Linmeng Li;Shuting Zhang;Xinyue Lai;Lu Xu. The relationship between telomere length and aging-related diseases.. Clinical and experimental medicine(IF=3.5). 2025. PMID:40044947. DOI: 10.1007/s10238-025-01608-z.
  • [42] Sarfaraz K Niazi. Telomere-targeted medicine: Bridging molecular mechanisms and clinical applications in age-related diseases.. Life sciences(IF=5.1). 2025. PMID:40812670. DOI: 10.1016/j.lfs.2025.123904.
  • [43] May Shawi;Chantal Autexier. Telomerase, senescence and ageing.. Mechanisms of ageing and development(IF=5.1). 2008. PMID:18215413. DOI: 10.1016/j.mad.2007.11.007.
  • [44] Xiaodan Wang;Hao Deng;Jingyi Lin;Kai Zhang;Jingyu Ni;Lan Li;Guanwei Fan. Distinct roles of telomerase activity in age-related chronic diseases: An update literature review.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie(IF=7.5). 2023. PMID:37738798. DOI: 10.1016/j.biopha.2023.115553.

MaltSci Intelligent Research Services

Search for more papers on MaltSci.com

Telomeres · Cellular Aging · Genomic Stability · Age-related Diseases · Lifestyle Factors


© 2025 MaltSci